Table 2 Clinical, biological and tumour responses (%)

From: Arterial phase enhancement and body mass index are predictors of response to chemoembolisation for liver metastases of endocrine tumours

 

Clinical response ( n =23)

Biological response ( n =38)

Tumour response ( n =67)

Complete response

61

18

1

Partial response

30

47

36

Stable disease

4.5

32

36

Progressive disease

4.5

3

27